Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yashasvini Sampathkumar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Breast Cancer Research and Treatment|October 31, 2024
Trends in exercise initiation and participation among employed breast cancer survivors undergoing curative treatmentSonal Oza, Sujata Patil, Yashasvini Sampathkumar, et al.
Work (Reading, Mass.)|March 26, 2026
Work accommodations described by a racially and socioeconomically diverse sample of women undergoing treatment for breast cancerCarolyn E Eberle, Yashasvini Sampathkumar, Susan Chimonas, et al.
Psycho-Oncology|March 12, 2025
Drivers of Job Loss Among Chinese Breast Cancer Survivors: A Qualitative AnalysisSusan Chimonas, Yashasvini Sampathkumar, Xiaoxiao Huang, et al.
BMC Women'S Health|March 16, 2025
Assessing the Impact of Lymphedema Therapy Referral on Breast Cancer Survivors' Lymphedema Knowledge: A Cross-Sectional SurveyMadelyn Klugman, Yashasvini Sampathkumar, Sujata Patil, et al.
JCO Oncology Practice|August 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer MeasureYashasvini Sampathkumar, Corrine I Voils, Gina L Mazza, et al.
JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
JCO Oncology Practice|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)Allison M Deal, Yashasvini Sampathkumar, Brenda F Ginos, et al.
Cancer|February 24, 2026
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancerMaria J Monroy-Iglesias, Kelli O'Connell, Jenna Bhimani, et al.
Journal of the National Cancer Institute|May 20, 2026
Response to Yu, Wang, and GeYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Journal of the National Cancer Institute|March 5, 2026
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Breast Cancer Research and Treatment|October 31, 2024
Trends in exercise initiation and participation among employed breast cancer survivors undergoing curative treatmentSonal Oza, Sujata Patil, Yashasvini Sampathkumar, et al.
Work (Reading, Mass.)|March 26, 2026
Work accommodations described by a racially and socioeconomically diverse sample of women undergoing treatment for breast cancerCarolyn E Eberle, Yashasvini Sampathkumar, Susan Chimonas, et al.
Psycho-Oncology|March 12, 2025
Drivers of Job Loss Among Chinese Breast Cancer Survivors: A Qualitative AnalysisSusan Chimonas, Yashasvini Sampathkumar, Xiaoxiao Huang, et al.
BMC Women'S Health|March 16, 2025
Assessing the Impact of Lymphedema Therapy Referral on Breast Cancer Survivors' Lymphedema Knowledge: A Cross-Sectional SurveyMadelyn Klugman, Yashasvini Sampathkumar, Sujata Patil, et al.
JCO Oncology Practice|August 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer MeasureYashasvini Sampathkumar, Corrine I Voils, Gina L Mazza, et al.
JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
JCO Oncology Practice|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)Allison M Deal, Yashasvini Sampathkumar, Brenda F Ginos, et al.
Cancer|February 24, 2026
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancerMaria J Monroy-Iglesias, Kelli O'Connell, Jenna Bhimani, et al.
Journal of the National Cancer Institute|May 20, 2026
Response to Yu, Wang, and GeYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Journal of the National Cancer Institute|March 5, 2026
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Pageof 2